It is a chemicals public limited company based in Vadodara, Gujarat, India, established in 1986.
1986 | Vadodara, Gujarat, India | ActiveRolex Pharmaceuticals Limited, a active public limited company, was established on 03 July 1986 in Vadodara, Gujarat, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24232GJ1986PLC008767. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.93 Cr.
It upholds a compliant status. Its leadership includes Amit Dilipkumar Joshi (Director), Ragini Dilipkumar Joshi (Director), Dilipbhai Hariprasad Joshi (Managing Director). Past directors included Nilam Sanatkumar Trivedi, Amit Dilipkumar Joshi, Sujal Manishbhai Patel. It holds no open charges and ₹1.54 Cr settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 4Th Floor,Mruduna Sadan Pratap Road, Vadodara, Gujarat, 390001.
U24232GJ1986PLC008767
008767
03 July 1986
₹5.00 Cr
₹3.93 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Rolex Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Dilipkumar Joshi | Director | 01 Jun 2010 | Current |
| Ragini Dilipkumar Joshi | Director | 06 Jan 1992 | Current |
| Dilipbhai Hariprasad Joshi | Managing Director | 03 Jul 1986 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Additional Director | 20 Nov 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rolex Pharmaceuticals Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 65.39% decrease. The company also saw a slight decrease in profitability, with a 5.14% decrease in profit. The company's net worth moved up by a moderate rise of 0.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Rolex Pharmaceuticals had a promoter holding of 25.13% and a public holding of 74.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹15,449,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 1994 | Industrial Development Bank Of India | ₹1.30 Cr | Satisfied |
| 08 Jul 1993 | Bank Of Baroda | ₹1.00 M | Satisfied |
| 27 Mar 1989 | Gujarat State Financial Corporation | ₹1.45 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Rolex Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rolex Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rolex Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rolex Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Progress on Rolex Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Ahmedabad. was documented.
Progress on A charge registered on 08 Jul 1993 via Charge ID 90315120 with Bank Of Baroda was fully satisfied on 07 Jun 2017. was documented.
The activity A charge registered on 31 Jan 1994 via Charge ID 90315204 with Industrial Development Bank Of India was fully satisfied on 14 Jul 2010. was completed.
Progress on A charge registered on 27 Mar 1989 via Charge ID 90314310 with Gujarat State Financial Corporation was fully satisfied on 02 Jul 2010. was documented.
The activity Amit Dilipkumar Joshi was appointed as a Director was appointed as a Director on 01 Jun 2010 & has been associated with this company since 15 years 6 months . was completed.
The CIN of Rolex Pharmaceuticals Limited is U24232GJ1986PLC008767.
Rolex Pharmaceuticals Limited is headquartered at 4Th Floor,Mruduna Sadan Pratap Road, Vadodara, Gujarat, 390001.
Rolex Pharmaceuticals Limited was incorporated on 03 July 1986.
The current directors of Rolex Pharmaceuticals Limited are
The primary industry of Rolex Pharmaceuticals Limited is Chemicals.
Rolex Pharmaceuticals Limited is unlisted.
The authorized capital of Rolex Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹3.93 Cr.
The compliance status of Rolex Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX